Lenalidomide may delay onset of myeloma-related bone, organ damage

ScienceDaily
Oct 28, 2019, 10:42 am57 pts
The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

UAF Study Links Beaver Expansion to Faster Arctic Thaw 130

Climate change is now warming the deepest parts of the Arctic Ocean 129

Hyundai’s 641 HP electric sports car is here, but it will be limited [Images] 127

Congo Basin nations roll out community payments for forest care 125

Gas Pipeline Proposals in Virginia Multiply Through the South—and Worry Community Activists 122

The Driver of Sargassum Blooms in the Atlantic Ocean 119

UK wind farms generate a record 22.7 GW of power on a single day 118

Researchers uncover the source of widespread 'forever chemical' contamination in North Carolina 117

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.